Emcure Pharmaceuticals Financials
NSE: EMCURE | BSE: 544210
₹2,160.40
₹183.80
(9.30%)
As on 04-Nov-2026IST
Market cap
₹41,254 Cr
Revenue (TTM)
₹10,234 Cr
P/E Ratio
37.7
P/B Ratio
7.7
Div. Yield
0.2 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
10,234.10
|
9,203.54
|
7,896.00
|
6,658.25
|
5,985.81
|
5,855.39
|
|
|
|
|
|
|
Total Income
|
10,245.27
|
9,335.01
|
7,968.78
|
6,715.24
|
6,031.72
|
5,918.86
|
|
|
|
|
|
|
Total Expenditure
|
8,141.47
|
7,457.80
|
6,427.14
|
5,428.53
|
4,804.63
|
4,525.48
|
|
|
|
|
|
|
EBITDA
|
2,092.63
|
1,745.74
|
1,468.85
|
1,229.72
|
1,181.18
|
1,329.91
|
|
|
|
|
|
|
Depreciation
|
430.12
|
415.05
|
384.13
|
312.41
|
260.12
|
244.86
|
|
|
|
|
|
|
EBIT
|
1,662.51
|
1,330.70
|
1,084.73
|
917.32
|
921.06
|
1,085.05
|
|
|
|
|
|
|
Interest
|
151.49
|
143.67
|
175.78
|
237.15
|
213.61
|
175.98
|
|
|
|
|
|
|
Other Income
|
11.17
|
131.47
|
72.79
|
56.99
|
45.91
|
63.47
|
|
|
|
|
|
|
Exceptional Items
|
-27.85
|
-31.35
|
-10.38
|
-9.93
|
-6.15
|
--
|
|
|
|
|
|
|
Profit before Tax
|
1,494.35
|
1,287.14
|
971.35
|
727.23
|
747.22
|
972.55
|
|
|
|
|
|
|
Provision for Tax
|
401.68
|
345.87
|
263.88
|
199.65
|
185.37
|
269.99
|
|
|
|
|
|
|
Profit after Tax
|
1,092.67
|
941.27
|
707.47
|
527.58
|
561.85
|
702.56
|
|
|
|
|
|
|
Minority Interest
|
0.82
|
-16.91
|
-26.14
|
-29.39
|
-29.83
|
-40.36
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
1,093.49
|
924.36
|
681.33
|
498.18
|
532.02
|
662.20
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
5,344.04
|
4,950.03
|
4,446.19
|
2,952.28
|
2,501.13
|
1,987.55
|
|
|
|
|
|
|
Minority Interest
|
0.82
|
26.64
|
195.37
|
169.48
|
148.53
|
126.59
|
|
|
|
|
|
|
Non-Current Liabilities
|
980.81
|
584.19
|
811.91
|
1,377.13
|
904.55
|
868.42
|
|
|
|
|
|
|
Current Liabilities
|
3,838.93
|
3,912.24
|
2,668.27
|
3,210.47
|
3,019.19
|
2,964.83
|
|
|
|
|
|
|
Total Liabilities
|
10,163.78
|
9,514.48
|
8,121.73
|
7,709.37
|
6,633.64
|
6,020.86
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
3,542.74
|
3,861.01
|
3,565.87
|
3,449.45
|
2,737.49
|
2,523.29
|
|
|
|
|
|
|
Current Assets
|
6,027.59
|
5,612.10
|
4,555.86
|
4,254.49
|
3,835.91
|
3,424.10
|
|
|
|
|
|
|
Total Assets
|
10,163.78
|
9,514.48
|
8,121.73
|
7,709.37
|
6,633.64
|
6,020.86
|
|
|
|
|
|
|
Total Debt*
|
--
|
1,204.08
|
731.70
|
2,072.49
|
2,181.61
|
2,077.27
|
|
|
|
|
|
|
Net Current Assets
|
2,188.66
|
1,699.86
|
1,887.59
|
1,044.02
|
816.72
|
459.27
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
258.92
|
393.94
|
285.51
|
96.95
|
12.07
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
943.55
|
851.71
|
1,097.24
|
746.85
|
768.21
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-1,193.06
|
-94.00
|
-712.51
|
-467.69
|
-788.79
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
343.43
|
-813.96
|
-164.21
|
-145.40
|
-151.85
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
93.92
|
-56.25
|
220.52
|
133.77
|
-172.44
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
58.75
|
48.76
|
35.96
|
27.50
|
29.42
|
36.62
|
|
|
|
|
|
|
Cash EPS (₹)
|
57.64
|
71.54
|
57.61
|
46.37
|
45.45
|
52.39
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
281.69
|
260.46
|
234.02
|
162.17
|
137.48
|
109.02
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.17
|
3.60
|
3.00
|
3.00
|
2.00
|
3.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
49.77
|
44.95
|
60.57
|
41.30
|
42.48
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
14.69
|
13.74
|
32.20
|
6.99
|
14.29
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
25.25
|
22.49
|
19.87
|
21.97
|
26.56
|
|
|
|
|
|
|
ROE (%)
|
21.65
|
20.09
|
19.19
|
19.45
|
25.21
|
33.19
|
|
|
|
|
|
|
ROA (%)
|
11.17
|
10.70
|
8.94
|
7.39
|
8.97
|
11.15
|
|
|
|
|
|
|
EBIT Margin (%)
|
16.24
|
14.46
|
13.74
|
13.78
|
15.39
|
18.53
|
|
|
|
|
|
|
Net Margin (%)
|
10.67
|
10.08
|
8.88
|
7.86
|
9.31
|
11.87
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
14.44
|
13.61
|
12.38
|
13.48
|
15.84
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
21.12
|
16.56
|
18.59
|
11.23
|
2.23
|
-3.32
|
|
|
|
|
|
|
EBIT Growth (%)
|
32.84
|
22.68
|
18.25
|
-0.41
|
-15.11
|
19.41
|
|
|
|
|
|
|
Net Profit Growth (%)
|
38.73
|
33.05
|
34.10
|
-6.10
|
-20.03
|
67.84
|
|
|
|
|
|
|
EPS Growth (%)
|
37.77
|
35.59
|
30.75
|
-6.52
|
-19.66
|
68.87
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
11.36
|
50.94
|
18.16
|
26.10
|
-12.81
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
37.73
|
32.73
|
29.84
|
--
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
7.72
|
6.13
|
4.58
|
--
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.17
|
0.23
|
0.28
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
20.24
|
16.68
|
13.55
|
1.57
|
1.55
|
1.40
|
|
|
|
|
|
|
Close Price (₹)
|
1,943.00
|
1,595.50
|
1,072.40
|
--
|
--
|
--
|
|
|
|
|
|
|
High Price (₹)
|
2,101.00
|
1,672.65
|
1,580.00
|
--
|
--
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
1,260.00
|
889.00
|
910.95
|
--
|
--
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
41,253.53
|
30,257.56
|
20,327.45
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.10
|
0.24
|
0.17
|
0.71
|
0.88
|
1.05
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.16
|
0.11
|
0.32
|
0.45
|
0.55
|
|
|
|
|
|
|
Current Ratio
|
1.57
|
1.43
|
1.71
|
1.33
|
1.27
|
1.15
|
|
|
|
|
|
|
Quick Ratio
|
0.92
|
0.82
|
0.98
|
0.85
|
0.81
|
0.67
|
|
|
|
|
|
|
Interest Coverage
|
10.86
|
9.96
|
6.53
|
4.07
|
4.50
|
6.53
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
26.69
|
27.84
|
25.36
|
27.92
|
27.54
|
22.35
|
|
|
|
|
|
|
Asset Turnover
|
1.05
|
1.07
|
1.01
|
0.95
|
0.97
|
0.95
|
|
|
|
|
|
|
Receivable days
|
--
|
88.68
|
87.83
|
94.32
|
88.49
|
84.97
|
|
|
|
|
|
|
Inventory Days
|
--
|
84.11
|
78.64
|
78.21
|
84.77
|
90.46
|
|
|
|
|
|
|
Payable days
|
--
|
176.65
|
174.97
|
193.72
|
194.85
|
188.82
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-3.86
|
-8.50
|
-21.19
|
-21.59
|
-13.39
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
